Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/142636| Title: | GLP-1 receptor agonists for obesity : eligibility across 99 countries |
| Authors: | Yoo, Sang Gune K. Teufel, Felix Theilmann, Michaela Si, Yajuan Toure, Elhadji A. Aryal, Krishna Bärnighausen, Till Bait, Abdul Barreto, Marta Bovet, Pascal Brant, Luisa C. Cuschieri, Sarah Damasceno, Albertino Farzadfar, Farshad Fawwad, Asher Geldsetzer, Pascal Hambleton, Ian R. Houehanou, Corine Howitt, Christina J⊘rgensen, Jutta González-Rivas, Juan P. Labadarios, Demetre Marcus, Maja Martins, Joao Mwalim, Omar Nieto-Martínez, Ramfis Odili, Augustine N. Orazumbekova, Binur Perman, Gastón Quesnel-Crooks, Sarah Moghaddam, Sahar Saeedi Sewpal, Ronel Sousa-Uva, Mafalda Sulola, Mubarak A. Venkataraman, Kavita Vollmer, Sebastian Xueling, Sim Atun, Rifat Banegas, José R. Franco, Juan V. A. Arnott, Clare Chandiwana, Nomathemba Huffman, Mark D. Davies, Justine Ali, Mohammed K. Flood, David Manne-Goehler, Jennifer |
| Keywords: | Obesity -- drug therapy Glucagon-like peptide receptors Anti-obesity agents Obesity -- Epidemiology Diabetes -- Prevention |
| Issue Date: | 2026 |
| Publisher: | Elsevier |
| Citation: | Yoo, S. G., Teufel, F., Theilmann, M., Si, Y., Toure, E. A., Aryal, K.,….Manne-Goehler, J. (2026). GLP-1 receptor agonists for obesity: eligibility across 99 countries. The Lancet Diabetes & Endocrinology, 14(2), 105-108. |
| Abstract: | Obesity is a complex, multifactorial condition defined by excessive adiposity and associated health risks. The rising prevalence of obesity contributes to the increasing global burden of obesityrelated diseases, such as type 2 diabetes and cardiovascular diseases, placing immense strain on health-care systems and economies worldwide. Behavioural interventions, such as diet and exercise, have long been the foundation of obesity management, yet many individuals face challenges in achieving and maintaining substantial long-term weight loss through these approaches alone, especially in current obesogenic environments. [excerpt] |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/142636 |
| Appears in Collections: | Scholarly Works - FacM&SAna |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| GLP 1 receptor agonists for obesity eligibility across 99 countries.pdf Restricted Access | 222.51 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.